Wegovy

Healthcare

Novo Nordisk’s Doing Brilliantly, Just Not Brilliantly Enough

Photo via Novo Nordisk

Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.

1 min read

Photo by Jetcityimage via iStock

Healthcare

Eli Lilly’s Weight-Loss Drug Finally Off FDA Shortage List

The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.

1 min read
Photo by Chemist4U via CC BY-SA 2.0

Healthcare

Making Weight-Loss Drugs Takes a Whole Lot of Muscle

In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.

1 min read
Photo by News Øresund – Johan Wessman via CC BY 2.0

Markets

Novo Nordisk Slips Amid Disappointing Wegovy Sales

Novo Nordisk’s share price fell over 8% on Wednesday after the company reported lower-than-expected sales of Wegovy.

2 min read

Photo illustration by Connor Lin / The Daily Upside, Photos by Blue Origin and Daniel Oberhaus via CC BY 4.0

Technology

The State of the Billionaire Space Race

Blue Origin is going slower than SpaceX, but it also nailed a massive rocket launch on the first try. Jeff Bezos is back in the space race.

5 min read
Photo by Web Summit via CC BY 2.0

Finance

Crypto-Friendly Neo-Broker eToro Files for IPO

The listing marks a potentially triumphant comeback story and an insult of sorts to the embattled London stock exchange.

2 min read
Photo by Jay R. via Pexels

Energy

Oil Markets Show Signs of Resilience and Retreat as 2025 Gets Underway

With the way things are going today, it’s becoming increasingly hard to figure out what’s going on with the oil market.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.